<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/">
  <channel>
    <title>Microbiome</title>
    <description>
      <![CDATA[]]>
    </description>
    <link>https://www.bioworld.com/rss</link>
    <language>en-us</language>
    <item>
      <title>UK study reveals inconsistencies in global microbiome research</title>
      <description>
        <![CDATA[The U.K. Medicines and Healthcare products Regulatory Agency is calling for unified standards to harmonize microbiome research, after revealing major inconsistencies in the results when labs around the world analyzed identical reference samples of gut bacteria.]]>
      </description>
      <guid>http://www.bioworld.com/articles/726564</guid>
      <pubDate>Fri, 21 Nov 2025 09:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/726564-uk-study-reveals-inconsistencies-in-global-microbiome-research</link>
      <media:content url="https://www.bioworld.com/ext/resources/2025/11/19/Probiotics-bacteria-on-white-background.webp?t=1763586319" type="image/jpeg" medium="image" fileSize="677715">
        <media:title type="plain">Probiotics, bacteria on white background</media:title>
      </media:content>
    </item>
    <item>
      <title>UK study reveals inconsistencies in global microbiome research</title>
      <description>
        <![CDATA[The U.K. Medicines and Healthcare products Regulatory Agency is calling for unified standards to harmonize microbiome research, after revealing major inconsistencies in the results when labs around the world analyzed identical reference samples of gut bacteria.]]>
      </description>
      <guid>http://www.bioworld.com/articles/726426</guid>
      <pubDate>Thu, 20 Nov 2025 09:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/726426-uk-study-reveals-inconsistencies-in-global-microbiome-research</link>
      <media:content url="https://www.bioworld.com/ext/resources/2025/11/19/Probiotics-bacteria-on-white-background.webp?t=1763586319" type="image/jpeg" medium="image" fileSize="677715">
        <media:title type="plain">Probiotics, bacteria on white background</media:title>
      </media:content>
    </item>
    <item>
      <title>‘Most complete’ map of oral microbiome enables links to systemic disease</title>
      <description>
        <![CDATA[South Korean researchers led by Lee In-suk of Yonsei University have reported the most complete oral microbiome catalog to date, with more than 72,000 genomes. Detailed in <em>Cell Host & Microbe</em> on Nov. 12, 2025, the database is expected to serve as a universal platform for academia and enable “precision microbiome medicine” for the industry, Lee told <em>BioWorld.</em>]]>
      </description>
      <guid>http://www.bioworld.com/articles/726351</guid>
      <pubDate>Tue, 18 Nov 2025 08:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/726351-most-complete-map-of-oral-microbiome-enables-links-to-systemic-disease</link>
      <media:content url="https://www.bioworld.com/ext/resources/BW-source/2020/Nov-2020/Science-microbiome-11-5.webp?t=1604592414" type="image/png" medium="image" fileSize="553641">
        <media:title type="plain">Microbiome illustration</media:title>
        <media:description type="plain">Credit: Darryl Leja, NHGRI</media:description>
      </media:content>
    </item>
    <item>
      <title>‘Most complete’ map of oral microbiome enables links to systemic disease</title>
      <description>
        <![CDATA[South Korean researchers led by Lee In-suk of Yonsei University have reported the most complete oral microbiome catalog to date, with more than 72,000 genomes. Detailed in <em>Cell Host & Microbe</em> on Nov. 12, 2025, the database is expected to serve as a universal platform for academia and enable “precision microbiome medicine” for the industry, Lee told <em>BioWorld.</em>]]>
      </description>
      <guid>http://www.bioworld.com/articles/726031</guid>
      <pubDate>Thu, 13 Nov 2025 08:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/726031-most-complete-map-of-oral-microbiome-enables-links-to-systemic-disease</link>
      <media:content url="https://www.bioworld.com/ext/resources/BW-source/2020/Nov-2020/Science-microbiome-11-5.webp?t=1604592414" type="image/png" medium="image" fileSize="553641">
        <media:title type="plain">Microbiome illustration</media:title>
        <media:description type="plain">Credit: Darryl Leja, NHGRI</media:description>
      </media:content>
    </item>
    <item>
      <title>Liver is also immune organ, influenced by microbiome</title>
      <description>
        <![CDATA[Immunity is not a function most people particularly associate with the liver. But because of its connection to the gut, the liver is exposed to bacterial metabolites as few other organs are. And when either the liver or the gut is not functioning well, it can adversely affect immunity as well.]]>
      </description>
      <guid>http://www.bioworld.com/articles/720281</guid>
      <pubDate>Wed, 14 May 2025 09:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/720281-liver-is-also-immune-organ-influenced-by-microbiome</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Therapeutic-topics/Gastrointestinal/Liver-illustration-purple.webp?t=1705415419" type="image/jpeg" medium="image" fileSize="218236">
        <media:title type="plain">Liver illustration </media:title>
      </media:content>
    </item>
    <item>
      <title>Liver is also immune organ, influenced by microbiome</title>
      <description>
        <![CDATA[Immunity is not a function most people particularly associate with the liver. But because of its connection to the gut, the liver is exposed to bacterial metabolites as few other organs are. And when either the liver or the gut is not functioning well, it can adversely affect immunity as well. The liver is connected to the gut via both the biliary system and the portal vein. Those two conduits allow metabolites from the gut microbiome to influence what’s going on in the liver. Both liver and gut damage can affect this communication for the worse. And surprisingly, one of the consequences is immune dysfunction.]]>
      </description>
      <guid>http://www.bioworld.com/articles/720072</guid>
      <pubDate>Mon, 12 May 2025 09:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/720072-liver-is-also-immune-organ-influenced-by-microbiome</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Therapeutic-topics/Gastrointestinal/Liver-illustration-purple.webp?t=1705415419" type="image/jpeg" medium="image" fileSize="218236">
        <media:title type="plain">Liver illustration </media:title>
      </media:content>
    </item>
    <item>
      <title>Synthetic microbiome prevents &lt;em&gt;Clostridioides difficile&lt;/em&gt; recurrences </title>
      <description>
        <![CDATA[Investigators at Pennsylvania State University have described a novel approach to combat <em>Clostridioides difficile</em> infection using a synthetic microbiome therapy, which offers an alternative to antibiotics and fecal microbiota transplant .]]>
      </description>
      <guid>http://www.bioworld.com/articles/718153</guid>
      <pubDate>Fri, 07 Mar 2025 09:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/718153-synthetic-microbiome-prevents-emclostridioides-difficile-em-recurrences</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Research-and-science/Microbiome-pic.webp?t=1588872675" type="image/png" medium="image" fileSize="546434">
        <media:title type="plain">Microbiome illustration</media:title>
      </media:content>
    </item>
    <item>
      <title>Synthetic microbiome prevents &lt;em&gt;Clostridioides difficile&lt;/em&gt; recurrences </title>
      <description>
        <![CDATA[Investigators at Pennsylvania State University have described a novel approach to combat <em>Clostridioides difficile</em> infection using a synthetic microbiome therapy, which offers an alternative to antibiotics and fecal microbiota transplant (FMT). <em>C. diff</em>, the main cause of antibiotic-related diarrhea, is responsible for an estimated half a million infections annually in the U.S.]]>
      </description>
      <guid>http://www.bioworld.com/articles/717879</guid>
      <pubDate>Thu, 06 Mar 2025 09:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/717879-synthetic-microbiome-prevents-emclostridioides-difficile-em-recurrences</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Research-and-science/Microbiome-pic.webp?t=1588872675" type="image/png" medium="image" fileSize="546434">
        <media:title type="plain">Microbiome illustration</media:title>
      </media:content>
    </item>
    <item>
      <title>Machine learning links microbiome composition to bacterial load</title>
      <description>
        <![CDATA[Many studies have linked the presence of specific bacteria to various diseases. But a general overgrowth of gut bacteria can be a symptom of different conditions, including colorectal cancer and inflammatory bowel disease. ]]>
      </description>
      <guid>http://www.bioworld.com/articles/714819</guid>
      <pubDate>Fri, 22 Nov 2024 12:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/714819-machine-learning-links-microbiome-composition-to-bacterial-load</link>
      <media:content url="https://www.bioworld.com/ext/resources/BWS/BWS-source/EMBL-Bork-Gut-hero.webp?t=1731686298" type="image/jpeg" medium="image" fileSize="663014">
        <media:title type="plain">Illustration of gut bacteria on scales being evaluated by AI chip</media:title>
        <media:description type="plain">A new machine learning approach helps scientists estimate the density of microbes in a human gut sample using sequencing data alone. Credit: Daniela Velasco Lozano/EMBL</media:description>
      </media:content>
    </item>
    <item>
      <title>Machine learning links microbiome composition to bacterial load</title>
      <description>
        <![CDATA[Many studies have linked the presence of specific bacteria to various diseases. But a general overgrowth of gut bacteria can be a symptom of different conditions, including colorectal cancer and inflammatory bowel disease. A study counting gut microbiome proposes that microbial load, rather than the disease, could explain the presence of certain pathogens.]]>
      </description>
      <guid>http://www.bioworld.com/articles/714645</guid>
      <pubDate>Tue, 19 Nov 2024 09:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/714645-machine-learning-links-microbiome-composition-to-bacterial-load</link>
      <media:content url="https://www.bioworld.com/ext/resources/BWS/BWS-source/EMBL-Bork-Gut-hero.webp?t=1731686298" type="image/jpeg" medium="image" fileSize="663014">
        <media:title type="plain">Illustration of gut bacteria on scales being evaluated by AI chip</media:title>
        <media:description type="plain">A new machine learning approach helps scientists estimate the density of microbes in a human gut sample using sequencing data alone. Credit: Daniela Velasco Lozano/EMBL</media:description>
      </media:content>
    </item>
    <item>
      <title>Machine learning links microbiome composition to bacterial load</title>
      <description>
        <![CDATA[Many studies have linked the presence of specific bacteria to various diseases. But a general overgrowth of gut bacteria can be a symptom of different conditions, including colorectal cancer and inflammatory bowel disease. A study counting gut microbiome proposes that microbial load, rather than the disease, could explain the presence of certain pathogens.]]>
      </description>
      <guid>http://www.bioworld.com/articles/714463</guid>
      <pubDate>Fri, 15 Nov 2024 09:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/714463-machine-learning-links-microbiome-composition-to-bacterial-load</link>
      <media:content url="https://www.bioworld.com/ext/resources/BWS/BWS-source/EMBL-Bork-Gut-hero.webp?t=1731686298" type="image/jpeg" medium="image" fileSize="663014">
        <media:title type="plain">Illustration of gut bacteria on scales being evaluated by AI chip</media:title>
        <media:description type="plain">A new machine learning approach helps scientists estimate the density of microbes in a human gut sample using sequencing data alone. Credit: Daniela Velasco Lozano/EMBL</media:description>
      </media:content>
    </item>
    <item>
      <title>New peptide antibiotics from the human microbiome</title>
      <description>
        <![CDATA[The gastrointestinal tract could be key to developing new drugs to combat resistant bacteria. Computational analysis of the human microbiome has revealed a new class of peptides with antimicrobial potential that, once synthesized, inhibited the growth of several microorganisms in vitro and in vivo. ]]>
      </description>
      <guid>http://www.bioworld.com/articles/711794</guid>
      <pubDate>Thu, 22 Aug 2024 09:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/711794-new-peptide-antibiotics-from-the-human-microbiome</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Therapeutic-topics/Infectious/Prevotella-bacteria.webp?t=1724339865" type="image/jpeg" medium="image" fileSize="403996">
        <media:title type="plain">3D illustration of Prevotella bacteria</media:title>
      </media:content>
    </item>
    <item>
      <title>System invented for mixing, filtering, and dosing of fecal transplantation capsules</title>
      <description>
        <![CDATA[The first patenting to emerge in the name of Copenhagen, Denmark-based 1Health Gut In Balance ApS (dba Gut In Balance) describes development of an apparatus and system that enables hospitals to produce fecal microbiota transplantation capsules on site, and much more efficiently and cheaply.]]>
      </description>
      <guid>http://www.bioworld.com/articles/710942</guid>
      <pubDate>Wed, 31 Jul 2024 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/710942-system-invented-for-mixing-filtering-and-dosing-of-fecal-transplantation-capsules</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2024/1health-gut-in-balance-fecal-microbiome-31july24.webp?t=1722462099" type="image/jpeg" medium="image" fileSize="145386">
        <media:title type="plain">1health-gut-in-balance-fecal-microbiome-31july24.jpg</media:title>
        <media:description type="plain">WO2024141422-A1, “An apparatus, kit and method for mixing, filtering, and dosing of a biological material.”"Assignee: 1Health Gut Inn Balance ApSInventors: Lauridsen, Hengameh ChloéIPC Codes: A61B 10/00Publication date: July 4, 2024Earliest priority details: DK20221227, Dec. 28, 2022</media:description>
      </media:content>
    </item>
    <item>
      <title>Phage-derived enzyme can help fight acute graft-vs.-host disease</title>
      <description>
        <![CDATA[Researchers in Japan have discovered that a phage-derived enzyme called endolysin, which targets highly resistant biofilm-forming bacteria, could help restore the gut microbiota to mitigate acute graft-vs.-host disease. Acute graft-vs.-host disease (aGVHD) is a common complication for patients who undergo allogeneic hematopoietic cell transplantation (allo-HCT). Recent studies have highlighted the significant role of the microbiome in aGVHD, with dysbiosis contributing to its pathogenesis.]]>
      </description>
      <guid>http://www.bioworld.com/articles/710541</guid>
      <pubDate>Tue, 16 Jul 2024 09:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/710541-phage-derived-enzyme-can-help-fight-acute-graft-vs-host-disease</link>
      <media:content url="https://www.bioworld.com/ext/resources/BW-source/2020/Nov-2020/Science-microbiome-11-5.webp?t=1604592414" type="image/png" medium="image" fileSize="553641">
        <media:title type="plain">Microbiome illustration</media:title>
        <media:description type="plain">Credit: Darryl Leja, NHGRI</media:description>
      </media:content>
    </item>
    <item>
      <title>Kanvas Biosciences raises funding to advance live biotherapeutic products for cancer patients</title>
      <description>
        <![CDATA[Kanvas Biosciences Inc. has raised $12.5 million in additional funding to support development of the company’s spatial biology platform and advance two novel therapeutics in its immuno-oncology program, KAN-001 and KAN-003.]]>
      </description>
      <guid>http://www.bioworld.com/articles/710049</guid>
      <pubDate>Tue, 02 Jul 2024 09:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/710049-kanvas-biosciences-raises-funding-to-advance-live-biotherapeutic-products-for-cancer-patients</link>
    </item>
    <item>
      <title>Gut microbe enzymes can produce universal donor blood cells</title>
      <description>
        <![CDATA[Researchers have identified enzymes in gut microorganisms that could cleave A and B antigens from red blood, transmuting them to O negative cells. ]]>
      </description>
      <guid>http://www.bioworld.com/articles/708291</guid>
      <pubDate>Fri, 03 May 2024 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/708291-gut-microbe-enzymes-can-produce-universal-donor-blood-cells</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Research-and-science/Blood-cell-test-tube-dropper.webp?t=1592429458" type="image/png" medium="image" fileSize="502610">
        <media:title type="plain">Blood cell, test tubes, dropper</media:title>
      </media:content>
    </item>
    <item>
      <title>Gut microbe enzymes can produce universal donor blood cells</title>
      <description>
        <![CDATA[Researchers have identified enzymes in gut microorganisms that could cleave A and B antigens from red blood, transmuting them to O negative cells. This is “a decisive step forward” in the quest to develop a universal donor blood that can be administered to people of any blood group without eliciting a harmful immune response, according to Maher Abou Hachem of the Technical University of Denmark, who co-led the research.]]>
      </description>
      <guid>http://www.bioworld.com/articles/708079</guid>
      <pubDate>Thu, 02 May 2024 09:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/708079-gut-microbe-enzymes-can-produce-universal-donor-blood-cells</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Research-and-science/Blood-cell-test-tube-dropper.webp?t=1592429458" type="image/png" medium="image" fileSize="502610">
        <media:title type="plain">Blood cell, test tubes, dropper</media:title>
      </media:content>
    </item>
    <item>
      <title>Commensal yeast species prevents candidiasis</title>
      <description>
        <![CDATA[Scientists at the Weizmann Institute of Science in Israel announced the discovery of the new intestinal microbiota species <em>Kazachstania weizmannii</em> in mice, which competed with and limited the growth of <em>Candida albicans</em>, thus preventing candidiasis. Both microorganisms belong to the Saccharomycetaceae family and reside in humans, maintaining a complex interaction with therapeutic value.]]>
      </description>
      <guid>http://www.bioworld.com/articles/706670</guid>
      <pubDate>Wed, 20 Mar 2024 09:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/706670-commensal-yeast-species-prevents-candidiasis</link>
      <media:content url="https://www.bioworld.com/ext/resources/BWS/BWS-library/Candida-albicans.webp?t=1710947506" type="image/jpeg" medium="image" fileSize="212857">
        <media:title type="plain">Candida albicans infection</media:title>
        <media:description type="plain">Candida albicans.</media:description>
      </media:content>
    </item>
    <item>
      <title>Study links microbiome, vitamin B12, tissue repair in ulcerative colitis</title>
      <description>
        <![CDATA[A laboratory technique used to generate pluripotent stem cells from any tissue, cellular reprogramming, has led a group of researchers to the discovery of a process that could have an impact on natural tissue repair.]]>
      </description>
      <guid>http://www.bioworld.com/articles/703088</guid>
      <pubDate>Fri, 24 Nov 2023 09:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/703088-study-links-microbiome-vitamin-b12-tissue-repair-in-ulcerative-colitis</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Therapeutic-topics/Gastrointestinal/Holographic-intestine.webp?t=1683669912" type="image/jpeg" medium="image" fileSize="171482">
        <media:title type="plain">Hands holding holographic intestine</media:title>
      </media:content>
    </item>
    <item>
      <title>Intestinal microbiota have a say in graft-vs-host disease</title>
      <description>
        <![CDATA[Avoidance of graft-vs.-host disease (GVHD) after a hematopoietic stem cell transplant could depend on certain members of the microbiome. According to a study led by scientists at the Fred Hutchinson Cancer Center (FHCC), while some species of intestinal bacteria repressed the expression of the major histocompatibility complex II (MHC-II), others induced it and triggered the immune response that produces GVHD.]]>
      </description>
      <guid>http://www.bioworld.com/articles/699297</guid>
      <pubDate>Mon, 24 Jul 2023 09:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/699297-intestinal-microbiota-have-a-say-in-graft-vs-host-disease</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Therapeutic-topics/Hematologic/Lab-sample-and-bone-marrow-illustration.webp?t=1643152719" type="image/png" medium="image" fileSize="469978">
        <media:title type="plain">Lab sample and bone marrow illustration</media:title>
      </media:content>
    </item>
    <item>
      <title>Microbiome member has sex-specific effects in colorectal cancer </title>
      <description>
        <![CDATA[Researchers from the Chinese University of Hong Kong have identified the <em>Carnobacterium maltaromaticum</em> bacterium as a potential oral probiotic prophylactic to increase vitamin D production and reinvigorate gut microbiota to prevent colorectal cancer (CRC) in women.]]>
      </description>
      <guid>http://www.bioworld.com/articles/699214</guid>
      <pubDate>Fri, 21 Jul 2023 09:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/699214-microbiome-member-has-sex-specific-effects-in-colorectal-cancer</link>
    </item>
    <item>
      <title>Intron identifies prophage and jamphage from microbiome found in long-term pancreatic cancer survivors</title>
      <description>
        <![CDATA[Intron Biotechnology Inc. has announced the identification of lysogenic bacteriophages prophage and jamphage in the pancreatic cancer-related microbiome. This identification was achieved as part of the ongoing Phageriarus development project that is focused on acquiring bacteriophage-derived proteins that can serve as immune regulators, with the ultimate goal of developing phage-based immunotherapeutics for immune disorders and cancer.]]>
      </description>
      <guid>http://www.bioworld.com/articles/697434</guid>
      <pubDate>Tue, 30 May 2023 09:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/697434-intron-identifies-prophage-and-jamphage-from-microbiome-found-in-long-term-pancreatic-cancer-survivors</link>
      <media:content url="https://www.bioworld.com/ext/resources/BWS/BWS-library/Cancer-tumor-microenvironment.webp?t=1668701295" type="image/png" medium="image" fileSize="1329459">
        <media:title type="plain">3D representation of tumor microenvironment</media:title>
      </media:content>
    </item>
    <item>
      <title>Altered gut microbiome contributes to symptoms of anorexia</title>
      <description>
        <![CDATA[Research led by the University of Copenhagen and Herlev-Gentofte University Hospital shows that individuals with the eating disorder anorexia nervosa have an abnormal gut microbiome that likely contributes to symptoms associated with the condition. Published in the April 17, 2023, issue of <em>Nature Microbiology</em>, the study showed multiple differences in the species and amounts of bacteria and viruses present in the gut of people with the condition compared with healthy controls.]]>
      </description>
      <guid>http://www.bioworld.com/articles/696288</guid>
      <pubDate>Fri, 21 Apr 2023 09:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/696288-altered-gut-microbiome-contributes-to-symptoms-of-anorexia</link>
    </item>
    <item>
      <title>Intron demonstrates inhibition of tumorigenesis using P18-BE3CRC in colorectal cancer organoid model</title>
      <description>
        <![CDATA[Intron Biotechnology Inc. has demonstrated the effectiveness of P18-BE3CRC using a cancer organoid model. ]]>
      </description>
      <guid>http://www.bioworld.com/articles/695740</guid>
      <pubDate>Tue, 04 Apr 2023 09:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/695740-intron-demonstrates-inhibition-of-tumorigenesis-using-p18-be3crc-in-colorectal-cancer-organoid-model</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Therapeutic-topics/Cancer/colon-cancer-cell.webp?t=1588881323" type="image/png" medium="image" fileSize="447411">
        <media:title type="plain">Colon cancer illustration</media:title>
      </media:content>
    </item>
    <item>
      <title>Hpvac-R13 prevents lung airway remodeling in mouse model of acute allergic asthma</title>
      <description>
        <![CDATA[Hpvac SA has announced promising results of its lead compound Hpvac-R13 on airway...]]>
      </description>
      <guid>http://www.bioworld.com/articles/695508</guid>
      <pubDate>Mon, 27 Mar 2023 09:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/695508-hpvac-r13-prevents-lung-airway-remodeling-in-mouse-model-of-acute-allergic-asthma</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Therapeutic-topics/Respiratory/Lungs2.webp?t=1589292447" type="image/png" medium="image" fileSize="340504">
        <media:title type="plain">Lungs</media:title>
      </media:content>
    </item>
    <item>
      <title>Condensates allow gut bacteria to adapt to the lean life</title>
      <description>
        <![CDATA[Gut bacteria used liquid-liquid phase separation (LLPS) to organize themselves into condensates, which allowed them to adapt to nutrient deprivation, enabling them to colonize the gut. In experiments reported in the March 17, 2023, issue of <em>Science</em>, investigators showed that a mutant of the beneficial gut bacterium <em>Bacteroides thetaiotaomicron</em> was “highly defective in competitiveness, in its ability to colonize the mammalian gut,” senior author Eduardo Groisman told <em>BioWorld</em>. “Our paper provides the first example in which [LLPS] matters in bacterial host interactions.”]]>
      </description>
      <guid>http://www.bioworld.com/articles/695293</guid>
      <pubDate>Tue, 21 Mar 2023 09:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/695293-condensates-allow-gut-bacteria-to-adapt-to-the-lean-life</link>
      <media:content url="https://www.bioworld.com/ext/resources/BWS/BWS-source/Cajal-statue.webp?t=1706404406" type="image/jpeg" medium="image" fileSize="605995">
        <media:title type="plain">Sculpture of Santiago Ramon y Cajal</media:title>
        <media:description type="plain">Cajal body. Pioneering neuroanatomist Santiago Ramón y Cajal first described Cajal bodies, a condensate in neurons, in 1903.</media:description>
      </media:content>
    </item>
    <item>
      <title>Intestinal bacteria prevent HIV infection in vitro</title>
      <description>
        <![CDATA[The intestinal microbiota could protect against HIV infection. At the 30th Conference on Retroviruses and Opportunistic Infections (CROI) last week, a group of scientists from Duke University presented data showing a preventive effect of two bacteria from the Lachnospiraceae family, the species <em>Clostridium immunis</em> and <em>Ruminococcus gnavus</em> against HIV. These microorganisms strongly inhibited HIV replication in vitro through the metabolic pathway of tryptophan and the aryl hydrocarbon receptor.]]>
      </description>
      <guid>http://www.bioworld.com/articles/694630</guid>
      <pubDate>Tue, 28 Feb 2023 09:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/694630-intestinal-bacteria-prevent-hiv-infection-in-vitro</link>
    </item>
    <item>
      <title>Intestinal oxygen protects against GVHD via microbiome</title>
      <description>
        <![CDATA[When oxygen levels of the intestine increase, the appropriate hypoxic conditions for intestinal microbiota are lost. This state may be caused by immune-mediated malfunction of the intestinal epithelium. By controlling oxygen levels, the imbalance in the intestinal microbiome (dysbiosis) can be reduced.]]>
      </description>
      <guid>http://www.bioworld.com/articles/694317</guid>
      <pubDate>Thu, 16 Feb 2023 09:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/694317-intestinal-oxygen-protects-against-gvhd-via-microbiome</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Research-and-science/Microbiome-pic.webp?t=1588872675" type="image/png" medium="image" fileSize="546434">
        <media:title type="plain">Microbiome illustration</media:title>
      </media:content>
    </item>
    <item>
      <title>Proteomic signature predicts responsiveness to exercise</title>
      <description>
        <![CDATA[Scientists have identified proteins that changed in response to exercise specifically in trial participants whose blood sugar control improved after taking up an exercise regimen. Based on serum protein analysis, the investigators also developed a machine-learning algorithm that could predict whether an individual’s metabolic sensitivity would be improved by exercise.]]>
      </description>
      <guid>http://www.bioworld.com/articles/694270</guid>
      <pubDate>Wed, 15 Feb 2023 09:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/694270-proteomic-signature-predicts-responsiveness-to-exercise</link>
    </item>
    <item>
      <title>Incomplete databases can yield false positives in microbiome studies</title>
      <description>
        <![CDATA[A study by researchers in Spain suggests that current metagenomic analyses of the microbiome can yield erroneous results, largely due to the incomplete databases that are used to identify microbial DNA sequences. A team led by Clemente Fernández Arias and Federica Bertocchini at the Centro de Investigaciones Biológicas Margarita Salas, Madrid, evaluated current microbiome analysis techniques on computer simulations of microbial communities in a report published on Feb. 8 in <em>PLOS ONE</em>.]]>
      </description>
      <guid>http://www.bioworld.com/articles/694171</guid>
      <pubDate>Mon, 13 Feb 2023 09:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/694171-incomplete-databases-can-yield-false-positives-in-microbiome-studies</link>
      <media:content url="https://www.bioworld.com/ext/resources/BWS/BWS-source/Virtualome-PLOS.webp?t=1676303290" type="image/png" medium="image" fileSize="588076">
        <media:title type="plain">Expected omics results vs. actual omics results</media:title>
        <media:description type="plain">Shortcomings of current metagenomic analyses. Credit: Serrano-Antón et al. PLoS ONE 2023, 18(2): e028039. CC-BY 4.0 (https://creativecommons.org/licenses/by/4.0/)</media:description>
      </media:content>
    </item>
  </channel>
</rss>
